PCG Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545K Sell
454
-7
-2% -$7.15K 0.39% 53
2026
Q1
$424K Buy
461
+1
+0.2% +$1.01K 0.34% 58
2025
Q4
$495K Sell
460
-5
-1% -$4.78K 0.39% 55
2025
Q3
$355K Buy
465
+24
+5% +$17.9K 0.28% 60
2025
Q2
$344K Buy
441
+12
+3% +$9.32K 0.3% 61
2025
Q1
$354K Buy
429
+138
+47% +$115K 0.33% 57
2024
Q4
$225K Buy
+291
New +$241K 0.2% 74

Other funds holding LLY

PCG Asset Management's LLY Position: Q2 2026 in Review

PCG Asset Management reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $7.15K and leaving 454 shares worth $545K. The position accounts for 0.39% of the portfolio, ranked #53.

PCG Asset Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PCG Asset Management held 454 shares of Eli Lilly worth $545K as of Q2 2026.
  • PCG Asset Management sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.39% of PCG Asset Management's portfolio in Q2 2026, its #53 holding.
  • PCG Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PCG Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.